Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma

Radical surgery‐peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer

“…Kaplan-Meier's overall survival rates of 33 patients with peritoneal carcinomatosis from primary ovarian cancer and recurrent ovarian cancer after radical-peritonectomy and hypertermic intraoperative intraperitoneal chemotherapy. improve survival rates of patients with peritoneal carcinomatosis from ovarian cancer as Sugarbaker described [7,[12][13][14][15]. Nevertheless, still hasn't turned into the standard treatment and there are few institutions that develop radical surgery associated to peritonectomy procedures and HIIC.…”

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma

“…Much has been written on the theoretical basis for CS, and there are a variety of descriptions of different techniques [20,[22][23][24][25]. Patients in this series had all gross tumor debulked and removed.…”

Malignant peritoneal mesothelioma

“…As the disease is treated earlier in its natural history through prompt referral to dedicated peritoneal surface malignancy treatment centers, the proportion of patients with a complete cytoreduction and thereby an opportunity for cure will increase [50]. With gaining more experience, the management of patients will become further clarified and the treatment modalities will become more refine.…”